Axsome
Axsome is a biotechnology firm that develops and commercializes novel therapies for the treatment of central nervous system disorders.
Business Model:
Revenue: $25.7M
Employees: 51-200
Industries / Tags:
Detailed Axsome Information
Geographic Data
Address: 22 Cortlandt Street
City: New York
State: NY
Zip: 10007
Country: US
Financial Info
Stage:
post ipo equity
Raised Last:
$200M
Raised Total:$207M
Social
Metrics
2,082,759Website Global Rank
9,655Website Monthly Traffic
Twitter Followers
Description
Axsome is a biotechnology firm that develops and commercializes novel therapies for the treatment of central nervous system disorders.
Contact Phone:
+12123323241
Contact Email:
Axsome went public on 11/20/2015 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
11/20/2015
Ticker Symbol:
AXSM
IPO Price:
$9/share
Amount Raised:
$51M
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 5/2015 | Venture Round | $2.5M | 9/2014 | Debt Financing | $2M | 9/2020 | Post-IPO Debt | $300M |
Hercules Capital, Inc. |
3/2019 | Post-IPO Debt | $24M |
Silicon Valley Bank WestRiver Innovation Lending Fund |
11/2015 | IPO | $51M |
|
1/2015 | Debt Financing | $1.3M | 12/2019 | Post-IPO Equity | $200M | 7/2013 | Debt Financing | $1.2M | 11/2016 | Post-IPO Debt | $20M |
Silicon Valley Bank |
|---|
| Announced Date | Name | Price |
|---|---|---|
| 5/2022 | SUNOSI |
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
